TransCode Therapeutics (RNAZ) Stock Chart & Stock Price History $7.08 -0.13 (-1.73%) As of 10:20 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TransCode Therapeutics Stock Price Performance The TransCode Therapeutics (RNAZ) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.98%, with a year-to-date return of -92.49%. In the past month, the stock has decreased 27.12%, reflecting recent market activity. As of the latest close, TransCode Therapeutics traded at $7.20 with a market cap of $6.00 million and volume of 37,496 shares. Receive RNAZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.77%1 Month Performance-27.12%3 Month Performance-65.90%Year-To-Date Performance-92.49%1 Year Performance-99.98% RNAZ Stock Chart for Friday, June, 13, 2025 RNAZ Chart by TradingView TransCode Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/12/2025$7.56$7.20-4.76%$7.91$7.1837,496 shs$6.00 million06/11/2025$7.37$7.56+2.58%$7.69$7.4316,357 shs$6.30 million06/10/2025$7.50$7.37-1.73%$7.62$7.2714,255 shs$6.14 million06/09/2025$7.14$7.50+5.04%$7.50$7.1435,960 shs$6.25 million06/06/2025$7.22$7.14-1.11%$7.46$7.0233,444 shs$5.95 million06/05/2025$7.39$7.22-2.30%$8.18$7.0758,710 shs$6.01 million06/04/2025$7.03$7.39+5.12%$7.49$7.0243,519 shs$6.16 million06/03/2025$7.09$7.03-0.85%$7.23$6.9623,598 shs$5.86 million06/02/2025$6.63$7.09+6.94%$7.36$6.8064,250 shs$5.91 million05/30/2025$6.90$6.63-3.91%$7.08$6.5437,208 shs$5.52 million Get the Latest News and Ratings for RNAZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/29/2025$6.97$6.90-1.00%$7.20$6.8549,886 shs$5.75 million05/28/2025$6.87$6.97+1.46%$7.46$6.8557,827 shs$5.81 million05/27/2025$6.97$6.87-1.43%$7.37$6.8041,015 shs$5.72 million05/26/2025$6.97$6.97$7.62$6.8763,917 shs$5.81 million05/23/2025$7.62$6.97-8.53%$7.62$6.8763,917 shs$5.81 million05/22/2025$7.94$7.62-4.03%$8.06$7.3069,377 shs$6.35 million05/21/2025$7.01$7.94+13.27%$8.53$6.83193,869 shs$6.61 million05/20/2025$6.70$7.01+4.63%$7.23$6.45159,888 shs$163.62 million05/19/2025$8.16$6.70-17.89%$8.28$6.15352,108 shs$156.39 million05/16/2025$7.65$8.16+6.67%$8.32$7.43111,382 shs$190.46 million05/15/2025$9.71$7.65-21.20%$8.99$7.19176,060 shs$178.56 million05/14/2025$9.72$9.71-0.14%$10.07$9.3637,949 shs$8.09 million05/13/2025$10.00$9.72-2.80%$9.95$9.0143,327 shs$8.10 million05/12/2025$9.29$10.00+7.66%$10.36$9.2463,479 shs$8.34 million Related Companies Cyclo Therapeutics Stock Chart Ovid Therapeutics Stock Chart Imunon Stock Chart CytoMed Therapeutics Stock Chart CASI Pharmaceuticals Stock Chart Lisata Therapeutics Stock Chart Enlivex Therapeutics Stock Chart Q32 Bio Stock Chart MIRA Pharmaceuticals Stock Chart Finch Therapeutics Group Stock Chart Receive RNAZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RNAZ) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransCode Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransCode Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
